BackNovartis AG Overview

Novartis AG Goodwill

Novartis AG's goodwill is $27B.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$26.71B
4.53% YoYΔ $1.16B vs prior year quarter

Peer trimmed avg / median

Loading

Novartis AG Goodwill History

Loading

Novartis AG vs. peers: Goodwill Comparison

Loading

Novartis AG Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Novartis AG (NVSEF) FAQ

As of the most recent data (June 2026), NVSEF shows a goodwill of $27B. That compares with $26B in the prior-year period — up 4.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NVSEF's goodwill is now $27B (was $26B) — a 4.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Novartis AG is outperforming or lagging.

Tracking NVSEF's goodwill over time shows whether Novartis AG is scaling, shrinking, or reshaping that part of the business. The current reading is $27B That compares with $26B in the prior-year period — up 4.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Novartis AG's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $27B) with ownership activity and broader fundamentals.

Novartis AG's goodwill is $27B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.